Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… Teveten HCT (Eprosartan Mesylate/Hydrochlorothiazide) Tablets, Biovail Technologies Ltd. 21-268/S6 7/7/03 7/10/03 | Teveten HCT (Eprosartan Mesylate/Hydrochlorothiazide) Tablets, Unimed 21-268 11/1/01 3/5/02 3/5/02 3/5/02 Teveten & HCT (Eprosartan Mesylate/Hydrochlorothiazide) Tablets, Biovail 20-738/S12 & 21-268/S2 10/16/03 10/17/03 | Teveten (Eprosartan Mesylate) Tablets, 300, 400 & 600 mg SmithKline Beecham NDA 20-738/S004 | Teveten HCT (eprosartan mesylate/hydrochlorothiazide) tablets, Kos Life Sciences, Control Supplement | Teveten (eprosartan mesylate) Tablets, Abbott Laboratories, Labeling Revision | Teveten HCT (eprosartan mesylate and hydrochlorothiazide) Tablets, Abbott Laboratories, Labeling Revision | Eprosartan Mesylate Tablets, Mylan Pharmaceuticals, Inc., Approval View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com